Ischemic Kidney Disease: a Modern Approach to the Problem
Journal Title: Нирки - Year 2015, Vol 4, Issue 14
Abstract
Today, a significant prevalence of ischemic kidney disease is proved, although it often remains undiagnosed during life. Because of this, the importance of a more detailed study of this disease by means of early diagnosis and treatment is growing.
Authors and Affiliations
M. I. Kravchenko, A. A. Horzov, S. B. Maidan
Keywords
Related Articles
- EP ID EP214860
- DOI -
- Views 77
- Downloads 0
Diagnostic Role of N-Acetyl-β-D-Glucosaminidase as an Early Marker of Kidney Damage
In many diseases of the kidneys, N-acetyl-β-D-glucosaminidase (NAG) in the urine is excreted in large quantities. A significant increase in NAG activity is observed at the primary and secondary kidney damage, heavy metal...
Ciliopathies, the Role of Wnt-Signaling Pathway in the Course of Acute (Postinfectious) Glomerulonephritis: Literature Review and Own Observations
Primary cilia — the cellular organelles derived from cytoplasmic cell membrane of almost any type. They play a role in the perception and the transfer of mechanical and chemical signals from the surface of cells, orienta...
The use of ceruloplasmin drugs for correction of anemia and intoxication in patients with chronic kidney disease
Anemia - reduction of the total number of erythrocytes and / or hemoglobin in the blood volume unit. Ceruloplasmin drugs are using for stimulation of hematopoiesis, detoxication (reduction of intoxication), immune recons...
Antibiotic resistance and vaccination in patients with urinary tract infection
Limited in experience of using uroantiseptics, even those manufactured in European countries, such as Furamag and Macmiror, excessive use of antibiotics, which causes antibiotic resistance in the EU countries and form re...
Guideline Summary NGC (2016): Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes
National Institute for Health and Care Excellence (NICE) June 14, 2016 – Canagliflozin (Invokana, Invokamet) and Dapagliflozin (Farxiga, Xigduo XR) External Web Site Policy: The U.S. Food and Drug Administration (FDA) ha...